- Report
- March 2025
- 186 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- March 2025
- 185 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- February 2025
- 182 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- January 2025
- 180 Pages
Global
From €3386EUR$3,825USD£2,933GBP
€3984EUR$4,500USD£3,451GBP
- Report
- May 2025
- 105 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- May 2025
- 187 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- May 2025
- 120 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- May 2025
- 159 Pages
Global
From €4205EUR$4,750USD£3,642GBP
- Report
- May 2025
- 150 Pages
Global
From €3409EUR$3,850USD£2,952GBP
- Report
- June 2025
- 400 Pages
Global
From €4382EUR$4,949USD£3,795GBP
- Report
- March 2025
- 79 Pages
Global
From €3500EUR$4,235USD£3,137GBP
- Report
- July 2025
- 209 Pages
Global
From €4422EUR$4,995USD£3,830GBP
- Report
- April 2025
- 387 Pages
Global
From €3984EUR$4,500USD£3,451GBP
- Report
- January 2025
- 182 Pages
Global
From €4422EUR$4,995USD£3,830GBP
- Report
- June 2025
- 300 Pages
Latin America
From €3425EUR$3,869USD£2,967GBP
- Report
- August 2024
- 180 Pages
Asia Pacific
From €3425EUR$3,869USD£2,967GBP
- Report
- July 2020
- 269 Pages
Global
From €3096EUR$3,497USD£2,681GBP
- Report
- October 2023
- 192 Pages
Global
From €4720EUR$5,518USD£3,950GBP
- Report
- February 2024
- 202 Pages
Global
From €4427EUR$5,000USD£3,834GBP
- Report
- October 2022
- 194 Pages
Global
From €4427EUR$5,000USD£3,834GBP

The Flu Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent and treat infectious diseases. Flu Vaccines are specifically designed to protect against influenza, a highly contagious virus that can cause severe illness and even death. Flu Vaccines are typically administered annually, and are recommended for people of all ages, including pregnant women and those with chronic health conditions.
Flu Vaccines are typically developed by pharmaceutical companies, and are then approved and distributed by government health agencies. In addition to traditional flu vaccines, there are also recombinant vaccines, which are produced using genetic engineering techniques.
Companies in the Flu Vaccine market include Sanofi Pasteur, GlaxoSmithKline, Merck & Co., Pfizer, and Novartis. Show Less Read more